BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37245639)

  • 1. The prognosis of elderly patients with hepatocellular carcinoma after curative hepatectomy a multicenter competing risk analysis.
    Lu Y; Liang L; Lu WF; Cheng J; Yao WF; Xie YM; Wang DD; Xu FQ; Xiao ZQ; Zhang JG; Liu JW; Zhang CW; Huang DS
    Clin Res Hepatol Gastroenterol; 2023 Aug; 47(7):102147. PubMed ID: 37245639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and long-term prognosis of beyond-Milan recurrence after hepatectomy for BCLC stage 0/A hepatocellular carcinoma: A large-scale multicenter study.
    Feng ZH; Wang MD; Chen Z; Sun LY; Xu X; Kong QY; Chen ZX; Zeng YY; Liang YJ; Chen ZY; Wang H; Zhou YH; Chen TH; Yao LQ; Li C; Pawlik TM; Lau WY; Shen F; Yang T
    Surgery; 2022 Oct; 172(4):1147-1155. PubMed ID: 35868902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perioperative factors related to the prognosis of elderly patients with hepatocellular carcinoma.
    Xu L; Xu Y; Li G; Yang B
    Eur J Med Res; 2022 Dec; 27(1):280. PubMed ID: 36494837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver resection in elderly patients with hepatocellular carcinoma: age does matter.
    Liu YW; Yong CC; Lin CC; Wang CC; Chen CL; Cheng YF; Wang JH; Yen YH
    Updates Surg; 2021 Aug; 73(4):1371-1380. PubMed ID: 33687694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods.
    Kuo MJ; Mo LR; Chen CL
    BMC Cancer; 2021 Mar; 21(1):250. PubMed ID: 33685409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of hepatectomy for elderly patients with hepatocellular carcinoma.
    Kishida N; Hibi T; Itano O; Okabayashi K; Shinoda M; Kitago M; Abe Y; Yagi H; Kitagawa Y
    Ann Surg Oncol; 2015 Sep; 22(9):3094-101. PubMed ID: 25582743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter analysis of long-term oncologic outcomes of hepatectomy for elderly patients with hepatocellular carcinoma.
    Xing H; Liang L; Wang H; Zhou YH; Pei YL; Li C; Zeng YY; Gu WM; Chen TH; Li J; Zhang YM; Wang MD; Zhang WG; Pawlik TM; Lau WY; Shen F; Wu MC; Yang T
    HPB (Oxford); 2020 Sep; 22(9):1314-1323. PubMed ID: 31980306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors and patterns of early recurrence after curative hepatectomy for hepatocellular carcinoma.
    Hirokawa F; Hayashi M; Asakuma M; Shimizu T; Inoue Y; Uchiyama K
    Surg Oncol; 2016 Mar; 25(1):24-9. PubMed ID: 26979637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender disparity in hepatocellular carcinoma recurrence after curative hepatectomy.
    Liang T; He Y; Mo S; Chen Z; Liao X; Zhou X; Yang C; Zhao S; Han C; Zhu G; Su H; Ye X; Peng T
    Ann Hepatol; 2022; 27(3):100695. PubMed ID: 35257933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma.
    Kamiyama T; Nakanishi K; Yokoo H; Kamachi H; Tahara M; Kakisaka T; Tsuruga Y; Todo S; Taketomi A
    World J Surg Oncol; 2012 Jun; 10():107. PubMed ID: 22697061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preoperative serum liver enzyme markers for predicting early recurrence after curative resection of hepatocellular carcinoma.
    Wang ZX; Jiang CP; Cao Y; Zhang G; Chen WB; Ding YT
    Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):178-85. PubMed ID: 25865691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of diabetes mellitus on the long-term prognosis of patients with hepatocellular carcinoma after hepatectomy.
    Shen GL; Lu Y; Liang L; Lu WF; Diao YK; Xiao ZQ; Zhang KJ; Zhang JG; Zhang CW; Liu J
    Expert Rev Gastroenterol Hepatol; 2022 May; 16(5):473-478. PubMed ID: 35387530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is serum alpha-fetoprotein useful for predicting recurrence and mortality specific to hepatocellular carcinoma after hepatectomy? A test based on propensity scores and competing risks analysis.
    Shim JH; Yoon DL; Han S; Lee YJ; Lee SG; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    Ann Surg Oncol; 2012 Nov; 19(12):3687-96. PubMed ID: 22644512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N; Hanazaki K
    J Am Coll Surg; 2004 Mar; 198(3):356-65. PubMed ID: 14992736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Surgical treatment of primary liver cancer:a report of 10 966 cases].
    Xia YX; Zhang F; Li XC; Kong LB; Zhang H; Li DH; Cheng F; Pu LY; Zhang CY; Qian XF; Wang P; Wang K; Wu ZS; Lyu L; Rao JH; Wu XF; Yao AH; Shao WY; Fan Y; You W; Dai XZ; Qin JJ; Li MY; Zhu Q; Wang XH
    Zhonghua Wai Ke Za Zhi; 2021 Jan; 59(1):6-17. PubMed ID: 33412628
    [No Abstract]   [Full Text] [Related]  

  • 16. Prognostic factors of disease-free and overall survival in patients with hepatocellular carcinoma undergoing partial hepatectomy in curative intent.
    Lurje G; Bednarsch J; Czigany Z; Amygdalos I; Meister F; Schöning W; Ulmer TF; Foerster M; Dejong C; Neumann UP
    Langenbecks Arch Surg; 2018 Nov; 403(7):851-861. PubMed ID: 30267147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential predictive factors for microvascular invasion in hepatocellular carcinoma classified within the Milan criteria.
    Imura S; Teraoku H; Yoshikawa M; Ishikawa D; Yamada S; Saito Y; Iwahashi S; Ikemoto T; Morine Y; Shimada M
    Int J Clin Oncol; 2018 Feb; 23(1):98-103. PubMed ID: 28875240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy.
    Shimada S; Kamiyama T; Orimo T; Nagatsu A; Asahi Y; Sakamoto Y; Kamachi H; Taketomi A
    World J Surg Oncol; 2020 Jun; 18(1):122. PubMed ID: 32522259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the risk factors and prognostic factors of hepatectomy for hepatocellular carcinoma in patients aged 80 years or more.
    Hamaoka M; Kobayashi T; Ishiyama K; Ohira M; Tahara H; Kuroda S; Iwako H; Okimoto S; Honmyo N; Ohdan H
    J Hepatobiliary Pancreat Sci; 2017 Jan; 24(1):58-64. PubMed ID: 27860361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-center experience on actual mid-term (≥5 years) and long-term (≥10 years) survival outcome in patients with hepatocellular carcinoma after curative hepatectomy: A bimodal distribution.
    Fung AKY; Cheng NMY; Chong CCN; Lee KF; Wong J; Cheung SYS; Lok HT; Lai PBS; Ng KKC
    Medicine (Baltimore); 2020 Nov; 99(48):e23358. PubMed ID: 33235106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.